Literature DB >> 18673575

The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria.

Sue J Lee1, Kasia Stepniewska, Nicholas Anstey, Elizabeth Ashley, Karen Barnes, Tran Quang Binh, Umberto D'Alessandro, Nicholas P J Day, Peter J de Vries, Grant Dorsey, Jean-Paul Guthmann, Mayfong Mayxay, Paul Newton, Francois Nosten, Piero Olliaro, Lyda Osario, Loretxu Pinoges, Ric Price, Mark Rowland, Frank Smithuis, Robert Taylor, Nicholas J White.   

Abstract

BACKGROUND: Malaria is a very important cause of anaemia in tropical countries. Anaemia is assessed either by measurement of the haematocrit or the haemoglobin concentration. For comparisons across studies, it is often necessary to derive one measure from the other.
METHODS: Data on patients with slide-confirmed uncomplicated falciparum malaria were pooled from 85 antimalarial drug trials conducted in 25 different countries, to assess the haemoglobin/haematocrit relationship at different time points in malaria. Using a linear random effects model, a conversion equation for haematocrit was derived based on 3,254 measurements from various time points (ranging from day 0 to day 63) from 1,810 patients with simultaneous measurements of both parameters. Haemoglobin was also estimated from haematocrit with the commonly used threefold conversion.
RESULTS: A good fit was obtained using Haematocrit = 5.62 + 2.60 * Haemoglobin. On average, haematocrit/3 levels were slightly higher than haemoglobin measurements with a mean difference (+/- SD) of -0.69 (+/- 1.3) for children under the age of 5 (n = 1,440 measurements from 449 patients).
CONCLUSION: Based on this large data set, an accurate and robust conversion factor both in acute malaria and in convalescence was obtained. The commonly used threefold conversion is also valid.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673575      PMCID: PMC2515851          DOI: 10.1186/1475-2875-7-149

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


Background

Malaria is a major cause of anaemia in tropical countries. It results from the obligatory destruction of parasitized erythrocytes, the accelerated destruction of normal erythrocytes, and variable dyserythropoiesis. Anaemia is assessed either by measurement of the haematocrit or the haemoglobin concentration. Clinical and epidemiological studies of malaria use either measure, so for comparisons across studies, it is often necessary to derive one measure from the other. Malaria is associated with increased acute phase protein concentrations and severe malaria increases erythrocyte rigidity, which may affect the relationship between haemoglobin and haematocrit. Recently, it has been suggested that the threefold conversion that is commonly used to equate the two measures (haemoglobin = haematocrit/3), consistently overestimates the haemoglobin concentration resulting in an underestimate of the prevalence of anaemia [1,2]. This is important as anaemia is an important measure both of the efficacy of antimalarial treatment and the effectiveness of malaria control programmes. Data from patients with slide-confirmed, uncomplicated falciparum malaria were pooled from 85 antimalarial drug trials conducted in 25 different countries, to assess the haemoglobin/haematocrit relationship at different time points in malaria.

Methods

There were 78,239 haematocrit (Ht) measurements from 17,739 patients compared with 26,863 haemoglobin (Hb) measurements from 13,092 patients. The conversion equation for haematocrit was based on 3,254 measurements from various timepoints from 1,810 patients with simultaneous measurements of both parameters (mean Hb 10.5 g/dl, standard deviation (SD) 2.5 g/dl; mean Ht 33.0%, SD 7.1%). Post-treatment follow-up ranged from 14 to 63 days. Haematocrit was measured by centrifugation for 673 patients and by conductivity for 1,137 patients. Because haematocrit or haemoglobin concentrations change during recovery from malaria, adjustment for time was included. The potential effect of age and sex on the haematocrit/haemoglobin relationship was also explored.

Results and discussion

As there was significant random variation within each individual as well as between individuals (Breusch and Pagan Lagrange multiplier test for random effects, p < 0.0001) [3] a linear random effects model was constructed using the equation: (where Ht is haematocrit (%), Hb is haemoglobin (g/dL), vi is the random effect for each individual, i, β is the coefficient for each parameter that the model estimated, eit is the deviation for each individual, i, at time, t, and α is the intercept) and obtained: Ht = 5.66 + 2.58 * Hb + 0.01 * time which explained approximately 80% of the variance in the model (r2 (within) = 0.63, r2 (between) = 0.82, r2 (overall) = 0.83). Age and sex did not significantly improve the model fit (p = 0.22 and p = 0.17, respectively). Although time contributed significantly to the model fit (95% CI 0.005, 0.023), its effect was very small. For example, a haematocrit value of 35.5% at day 0 would change to 35.78% (35.5 + 0.28) on day 28 if time were taken into account. A simpified conversion without the time covariate using a random effects model gave: The model fit was still good (r2 (within) = 0.63, r2 (between) = 0.82, r2 (overall) = 0.82; Figure 1a).
Figure 1

a) Plot of observed versus predicted haematocrit measurements with a line to depict the relationship with the actual haematocrit values, b) Bland-Altman plot of agreement between actual haematocrit measurements and haematocrit values estimated from haemoglobin measurements.

a) Plot of observed versus predicted haematocrit measurements with a line to depict the relationship with the actual haematocrit values, b) Bland-Altman plot of agreement between actual haematocrit measurements and haematocrit values estimated from haemoglobin measurements. Using a Bland -Altman plot [4] to compare the values obtained using the conversion equation with the original observed values, the mean difference was -0.019 (95% CI -0.12 to 0.09) percentage points indicating that, overall, the predictions from the conversion equation tended to give slightly lower haematocrit estimates by up to 0.12 percentage points (Figure 1b). However, the conversion equation also overestimated haematocrit by up to 0.23 percentage points. Limits of agreement were calculated as the mean difference ± 1.96 SD and 94.3% of the values fell within these limits. Comparing these results with those reported by Carneiro et al, haemoglobin was also estimated from haematocrit with the commonly used threefold conversion using data from children under the age of five only (n = 1,440 measurements from 449 patients). The Bland-Altman plot showed good agreement when comparing haemoglobin in the field and values estimated using the threefold conversion. On average, haematocrit/3 levels were slightly higher than haemoglobin measurements with a mean difference (± SD; 95% CI) of -0.69 (± 1.3; -0.75 to -0.62). 74.2% of haematocrit/3 levels were higher than haemoglobin measurements. In contrast to Carneiro et al, but similar to Rodriguez-Morales et al, larger negative differences were not observed with decreasing haemoglobin levels (Figure 2a). Agreement was also good when applying the threefold conversion to measurements from patients between five and 14 years of age (n = 501 measurements from 216 patients, Figure 2b), but was best when used in adults (15 years and older, n = 1,306 measurements from 376 patients, Figure 2c).
Figure 2

Bland-Altman plots of agreement between actual haemoglobin measurements and haemoglobin values estimated from haematocrit measurements, by age group (Note: age was missing for seven patients).

Bland-Altman plots of agreement between actual haemoglobin measurements and haemoglobin values estimated from haematocrit measurements, by age group (Note: age was missing for seven patients).

Conclusion

In summary, based on this large data set, the conversion factor to equate haemoglobin and haematocrit (Ht = 5.62 + 2.60 * Hb) is accurate and robust both in acute uncomplicated malaria and in convalescence. The two measures can be readily interconverted. The commonly used threefold conversion is also valid.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

NJW, KS and SJL conceived the idea for paper. The data were collected from research that was designed and conducted by all the other authors. KS and SJL conducted the analysis and wrote the paper, with input from NJW and all other authors.
  3 in total

1.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

2.  Haemoglobin and haematocrit: is the threefold conversion valid for assessing anaemia in malaria-endemic settings?

Authors:  Ilona A Carneiro; Chris J Drakeley; Seth Owusu-Agyei; Bruno Mmbando; Daniel Chandramohan
Journal:  Malar J       Date:  2007-05-22       Impact factor: 2.979

3.  Haemoglobin and haematocrit: the threefold conversion is also non valid for assessing anaemia in Plasmodium vivax malaria-endemic settings.

Authors:  Alfonso J Rodríguez-Morales; Elia Sánchez; Melissa Arria; Miguel Vargas; Carmelina Piccolo; Rosa Colina; Carlos Franco-Paredes
Journal:  Malar J       Date:  2007-12-17       Impact factor: 2.979

  3 in total
  25 in total

1.  In vivo parasitological measures of artemisinin susceptibility.

Authors:  Kasia Stepniewska; Elizabeth Ashley; Sue J Lee; Nicholas Anstey; Karen I Barnes; Tran Quang Binh; Umberto D'Alessandro; Nicholas P J Day; Peter J de Vries; Grant Dorsey; Jean-Paul Guthmann; Mayfong Mayxay; Paul N Newton; Piero Olliaro; Lyda Osorio; Ric N Price; Mark Rowland; Frank Smithuis; Walter R J Taylor; François Nosten; Nicholas J White
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

2.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

3.  Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa.

Authors:  Julien Zwang; Jean-Louis Ndiaye; Abdoulaye Djimdé; Grant Dorsey; Andreas Mårtensson; Corine Karema; Piero Olliaro
Journal:  Malar J       Date:  2012-01-25       Impact factor: 2.979

4.  Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.

Authors:  Salim Abdulla; Elizabeth A Ashley; Quique Bassat; Delia Bethell; Anders Björkman; Steffen Borrmann; Umberto D'Alessandro; Prabin Dahal; Nicholas P Day; Mahamadou Diakite; Abdoulaye A Djimde; Arjen M Dondorp; Socheat Duong; Michael D Edstein; Rick M Fairhurst; M Abul Faiz; Catherine Falade; Jennifer A Flegg; Carole Fogg; Raquel Gonzalez; Brian Greenwood; Philippe J Guérin; Jean-Paul Guthmann; Kamal Hamed; Tran Tinh Hien; Ye Htut; Elizabeth Juma; Pharath Lim; Andreas Mårtensson; Mayfong Mayxay; Olugbenga A Mokuolu; Clarissa Moreira; Paul Newton; Harald Noedl; Francois Nosten; Bernhards R Ogutu; Marie A Onyamboko; Seth Owusu-Agyei; Aung Pyae Phyo; Zul Premji; Ric N Price; Sasithon Pukrittayakamee; Michael Ramharter; Issaka Sagara; Youry Se; Seila Suon; Kasia Stepniewska; Stephen A Ward; Nicholas J White; Peter A Winstanley
Journal:  Malar J       Date:  2015-09-22       Impact factor: 2.979

5.  Point-of-Care Testing for Anaemia in Children Using Portable Haematocrit Meter: A Pilot Study from Southwest Nigeria and Implications for Developing Countries.

Authors:  Oladele Olatunya; Olatunde Ogundare; Abiola Olaleye; Oyinkansola Agaja; Evelyn Omoniyi; Babajide Adeyefa; Kehinde Oluwadiya; Oyeku Oyelami
Journal:  Ethiop J Health Sci       Date:  2016-05

6.  Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Bangladeshi Individuals.

Authors:  Suprovath Kumar Sarker; Md Tarikul Islam; Grace Eckhoff; Mohammad Amir Hossain; Syeda Kashfi Qadri; A K M Muraduzzaman; Golam Sarower Bhuyan; Mohammod Shahidullah; Mohammad Abdul Mannan; Sarabon Tahura; Manzoor Hussain; Shahida Akhter; Nazmun Nahar; Tahmina Shirin; Firdausi Qadri; Kaiissar Mannoor
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

Review 7.  Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data.

Authors: 
Journal:  BMC Med       Date:  2015-09-18       Impact factor: 8.775

Review 8.  Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.

Authors:  Prabin Dahal; Umberto d'Alessandro; Grant Dorsey; Philippe J Guerin; Christian Nsanzabana; Ric N Price; Carol H Sibley; Kasia Stepniewska; Ambrose O Talisuna
Journal:  BMC Med       Date:  2015-09-07       Impact factor: 8.775

9.  Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.

Authors:  Nicholas M Douglas; Julie A Simpson; Aung Pyae Phyo; Hadjar Siswantoro; Armedy R Hasugian; Enny Kenangalem; Jeanne Rini Poespoprodjo; Pratap Singhasivanon; Nicholas M Anstey; Nicholas J White; Emiliana Tjitra; Francois Nosten; Ric N Price
Journal:  J Infect Dis       Date:  2013-06-12       Impact factor: 5.226

10.  PRELIMINARY REPORT ON THE PUTATIVE ASSOCIATION OF IL10 -3575 T/A GENETIC POLYMORPHISM WITH MALARIA SYMPTOMS.

Authors:  Wilson Domingues; Kelly Aparecida Kanunfre; Jonatas Cristian Rodrigues; Leandro Emidio Teixeira; Lidia Yamamoto; Thelma Suely Okay
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-04-08       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.